181 related articles for article (PubMed ID: 11447825)
1. Modulation of beta-amyloid production and fibrillization.
Allsop D; Twyman LJ; Davies Y; Moore S; York A; Swanson L; Soutar I
Biochem Soc Symp; 2001; (67):1-14. PubMed ID: 11447825
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
3. The Alzheimer's plaques, tangles and memory deficits may have a common origin; part I; a calcium deficit hypothesis.
Chen M
Front Biosci; 1998 May; 3():a27-31. PubMed ID: 9576681
[TBL] [Abstract][Full Text] [Related]
4. Fibrillogenesis of beta-amyloid.
Allsop D; Howlett D; Christie G; Karran E
Biochem Soc Trans; 1998 Aug; 26(3):459-63. PubMed ID: 9765896
[No Abstract] [Full Text] [Related]
5. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
Tamaoka A
Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
[TBL] [Abstract][Full Text] [Related]
6. The molecular pathology of amyloid deposition in Alzheimer's disease.
Martins RN; Robinson PJ; Chleboun JO; Beyreuther K; Masters CL
Mol Neurobiol; 1991; 5(2-4):389-98. PubMed ID: 1823142
[No Abstract] [Full Text] [Related]
7. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
Tomiyama T
Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
[TBL] [Abstract][Full Text] [Related]
8. [Pathogenesis of Alzheimer's disease: molecular and cellular mechanisms].
Govaerts L; Schoenen J; Bouhy D
Rev Med Liege; 2007 Apr; 62(4):209-16. PubMed ID: 17566391
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease: Mental plaque removal.
De Strooper B; Woodgett J
Nature; 2003 May; 423(6938):392-3. PubMed ID: 12761533
[No Abstract] [Full Text] [Related]
10. Potential novel targets for Alzheimer pharmacotherapy: I. Secretases.
Maiorini AF; Gaunt MJ; Jacobsen TM; McKay AE; Waldman LD; Raffa RB
J Clin Pharm Ther; 2002 Jun; 27(3):169-83. PubMed ID: 12081630
[TBL] [Abstract][Full Text] [Related]
11. The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught?
Verdile G; Fuller S; Atwood CS; Laws SM; Gandy SE; Martins RN
Pharmacol Res; 2004 Oct; 50(4):397-409. PubMed ID: 15304237
[TBL] [Abstract][Full Text] [Related]
12. Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.
Steiner H; Capell A; Leimer U; Haass C
Eur Arch Psychiatry Clin Neurosci; 1999; 249(6):266-70. PubMed ID: 10653281
[TBL] [Abstract][Full Text] [Related]
13. Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments.
Kaneko I; Morimoto K; Kubo T
Neuroscience; 2001; 104(4):1003-11. PubMed ID: 11457586
[TBL] [Abstract][Full Text] [Related]
14. Unraveling Alzheimer's. Scientists are close to figuring out how the disorder destroys brains. But will their knowledge save lives?
Gorman C
Time; 2000 Jul; 156(2):98-9. PubMed ID: 10977415
[No Abstract] [Full Text] [Related]
15. Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs.
Thakral S; Yadav A; Singh V; Kumar M; Kumar P; Narang R; Sudhakar K; Verma A; Khalilullah H; Jaremko M; Emwas AH
Ageing Res Rev; 2023 Jul; 88():101960. PubMed ID: 37224884
[TBL] [Abstract][Full Text] [Related]
16. Mouse models of Alzheimer's disease: the long and filamentous road.
Phinney AL; Horne P; Yang J; Janus C; Bergeron C; Westaway D
Neurol Res; 2003 Sep; 25(6):590-600. PubMed ID: 14503012
[TBL] [Abstract][Full Text] [Related]
17. Amyloid metabolism and secretases in Alzheimer's disease.
Xia W
Curr Neurol Neurosci Rep; 2001 Sep; 1(5):422-7. PubMed ID: 11898552
[TBL] [Abstract][Full Text] [Related]
18. [Recent advances in Alzheimer's disease].
Morishima-Kawashima M; Ihara Y
Seikagaku; 2001 Nov; 73(11):1297-307. PubMed ID: 11831025
[No Abstract] [Full Text] [Related]
19. Aberrant proteolytic processing and therapeutic strategies in Alzheimer disease.
Tomita T
Adv Biol Regul; 2017 May; 64():33-38. PubMed ID: 28082052
[TBL] [Abstract][Full Text] [Related]
20. APP transgenic mouse models and their use in drug discovery to evaluate amyloid- lowering therapeutics.
Hussain I
CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):395-402. PubMed ID: 20522015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
